Team 14: Development of Targeted Imaging and Therapy for Cancer and Inflammation (IT2D)

Recent advances in imaging and targeted therapy are paving the way for coupled diagnostic and therapeutic actions in the fight against cancer. The IT2D team is developing new theranostic methods for better targeting the activation of therapeutic vectors. Its approach is based, on the one hand, on the development and characterization of new nanosystems for therapeutic targeting and, on the other hand, on the development of new biomarkers in medical imaging and anatomopathology. The aim is to study changes in the tumour during therapy. This research, integrating multi-scale and multi-modal biomedical imaging, involves experimentation and mathematical modelling to better understand the therapeutic response. Located at the interface of life sciences and engineering, they contribute to the development of knowledge on the influence of the tumour environment on the therapeutic effect and to better patient management by broadening the arsenal of diagnostic and therapeutic means.   Website: https://www.lib.upmc.fr/?page_id=145 Affiliations: UPMC/INSERM UMR_S1146 /CNRS UMR7371 laboratoire d’imagerie biomédicale Contact: lori.bridal@upmc.fr

• 
• 
• 
• 
•